CRISPR Screens Reveal Epstein-Barr Virus-activated JunB as a Key Lymphoblastoid B cell Dependency Factor that Represses Cyclin Dependent Kinase Inhibitor P18INK4c
This study identifies EBV-activated JunB as a critical dependency factor in lymphoblastoid B cells that drives proliferation by repressing the cell cycle inhibitor p18INK4c via an LMP1-NF-κB signaling axis, highlighting JunB as a promising therapeutic target for EBV-associated lymphoproliferative disorders.